Microgeographic Proteomic Networks of the Human Colonic Mucosa and Their Association With Inflammatory Bowel Disease

Cellular and Molecular Gastroenterology and Hepatology

Volumn 2, Issue 5, 2016, Pages 567-583

  Li, Xiaoxiao ^a,b   LeBlanc, James ^a   Elashoff, David ^a   McHardy, Ian ^a   Tong, Maomeng ^a   Roth, Bennett ^a   Ippoliti, Andrew ^b   Barron, Gildardo ^b   McGovern, Dermot ^b   McDonald, Keely ^c   Newberry, Rodney ^c   Graeber, Thomas ^a   Horvath, Steve ^a   Goodglick, Lee ^a   Braun, Jonathan ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Ecology; Inflammatory Bowel Disease; Metaproteomics; Mucosal; Networks

Indexed keywords

ALPHA 1 ANTITRYPSIN; ALPHA DEFENSIN; ALPHA DEFENSIN 1; ALPHA DEFENSIN 2; ALPHA DEFENSIN 3; ALPHA DEFENSIN 5; ASAH2 PROTEIN; BETA DEFENSIN 1; BETA DEFENSIN 2; BIOLOGICAL MARKER; CHYMOTRYPSIN C PREPROPROTEIN; CHYMOTRYPSIN LIKE ELASTASE FAMILY MEMBER 2A; DYNAMIN LIKE PROTEIN; ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 7; ELASTASE; ELASTASE 2A PREPROPROTEIN; GUANOSINE TRIPHOSPHATASE ACTIVATING RAP RANGAP DOMAIN LIKE 1 ISOFORM 1; HEPCIDIN; HNP PROTEIN; HUMAN NEUTROPHIL PEPTIDE; IMMUNOGLOBULIN HEAVY CHAIN; PANCREATIC AMYLASE ALPHA 2A; PEPTIDASE M20 DOMAIN CONTAINING 1; PROCARBOXYPEPTIDASE B; PROTEIN; PROTEIN TYROSINE KINASE; PROTEOME; TETRATRICOPEPTIDE REPEAT PROTEIN; TETRATRICOPEPTIDE TPR 2 REPEAT PROTEIN; TRANSFERRIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASCENDING COLON; BIOINFORMATICS; CECUM; COHORT ANALYSIS; COLON LAVAGE; COLON MUCOSA; COLONOSCOPY; CONTROLLED STUDY; CROHN DISEASE; DESCENDING COLON; DISEASE ASSOCIATION; ENDOSCOPIC BIOPSY; FEMALE; GASTROINTESTINAL TRACT; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INFLAMMATORY BOWEL DISEASE; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METAPROTEOMICS; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; RECTUM; SIGMOID; TRANSVERSE COLON; ULCERATIVE COLITIS;

EID: 84999751792     PISSN: None     EISSN: 2352345X     Source Type: Journal    
DOI: 10.1016/j.jcmgh.2016.05.003     Document Type: Article

References (49)

1. 1 Blikslager, A.T., Moeser, A.J., Gookin, J.L., et al. Restoration of barrier function in injured intestinal mucosa. Physiol Rev 87 (2007), 545–564.
2. 2 Sansonetti, P.J., War and peace at mucosal surfaces. Nat Rev Immunol 4 (2004), 953–964.
3. 3 Badman, M.K., Flier, J.S., The gut and energy balance: visceral allies in the obesity wars. Science 307 (2005), 1909–1914.
4. 4 Lewis, J.D., Chen, E.Z., Baldassano, R.N., et al. Inflammation, antibiotics, and diet as environmental stressors of the gut microbiome in pediatric Crohn's disease. Cell Host Microbe 18 (2015), 489–500.
5. 5 Dethlefsen, L., McFall-Ngai, M., Relman, D.A., An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature 449 (2007), 811–818.
6. 6 Costello, E.K., Lauber, C.L., Hamady, M., et al. Bacterial community variation in human body habitats across space and time. Science 326 (2009), 1694–1697.
7. 7 Morgan, X.C., Huttenhower, C., Meta'omic analytic techniques for studying the intestinal microbiome. Gastroenterology 146 (2014), 1437–1448 e1.
8. 8 McGovern, D.P., Kugathasan, S., Cho, J.H., Genetics of inflammatory bowel diseases. Gastroenterology 149 (2015), 1163–1176 e2.
9. 9 Lee, D., Albenberg, L., Compher, C., et al. Diet in the pathogenesis and treatment of inflammatory bowel diseases. Gastroenterology 148 (2015), 1087–1106.
10. 10 Li, X., LeBlanc, J., Truong, A., et al. A metaproteomic approach to study human-microbial ecosystems at the mucosal luminal interface. PLoS One, 6, 2011, e26542.
11. 11 Verberkmoes, N.C., Russell, A.L., Shah, M., et al. Shotgun metaproteomics of the human distal gut microbiota. ISME J 3 (2009), 179–189.
12. 12 Lichtman, J.S., Marcobal, A., Sonnenburg, J.L., et al. Host-centric proteomics of stool: a novel strategy focused on intestinal responses to the gut microbiota. Mol Cell Proteomics 12 (2013), 3310–3318.
13. 13 Lee, S.M., Donaldson, G.P., Mikulski, Z., et al. Bacterial colonization factors control specificity and stability of the gut microbiota. Nature 501 (2013), 426–429.
14. 14 Lichtman, J.S., Alsentzer, E., Jaffe, M., et al. The effect of microbial colonization on the host proteome varies by gastrointestinal location. ISME J 10 (2016), 1170–1181.
15. 15 Lichtman, J.S., Ferreyra, J.A., Ng, K.M., et al. Host-microbiota interactions in the pathogenesis of antibiotic-associated diseases. Cell Rep 14 (2016), 1049–1061.
16. 16 Earle, K.A., Billings, G., Sigal, M., et al. Quantitative imaging of gut microbiota spatial organization. Cell Host Microbe 18 (2015), 478–488.
17. 17 Eckburg, P.B., Bik, E.M., Bernstein, C.N., et al. Diversity of the human intestinal microbial flora. Science 308 (2005), 1635–1638.
18. 18 Frank, D.N., St Amand, A.L., Feldman, R.A., et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 104 (2007), 13780–13785.
19. 19 Costello, E.K., Stagaman, K., Dethlefsen, L., et al. The application of ecological theory toward an understanding of the human microbiome. Science 336 (2012), 1255–1262.
20. 20 Lustgarten, J.L., Kimmel, C., Ryberg, H., et al. EPO-KB: a searchable knowledge base of biomarker to protein links. Bioinformatics 24 (2008), 1418–1419.
21. 21 Kumar, A.R., Li, X., Leblanc, J.F., et al. Proteomic analysis reveals innate immune activity in intestinal transplant dysfunction. Transplantation 92 (2011), 112–119.
22. 22 Lorenz, R.G., Chaplin, D.D., McDonald, K.G., et al. Isolated lymphoid follicle formation is inducible and dependent upon lymphotoxin-sufficient B lymphocytes, lymphotoxin β receptor, and TNF receptor I function. J Immunol 170 (2003), 5475–5482.
23. 23 Scherer, A., Batch effects and noise in microarray experiments: sources and solutions. 2009, J. Wiley, Chichester, UK.
24. 24 Zhang, B., Horvath, S., A general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol Biol, 4, 2005 Article17.
25. 25 Langfelder, P., Horvath, S., WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics, 9, 2008, 559.
26. 26 Nugent, R., Meila, M., An overview of clustering applied to molecular biology. Methods Mol Biol 620 (2010), 369–404.
27. 27 Jay, J.J., Eblen, J.D., Zhang, Y., et al. A systematic comparison of genome-scale clustering algorithms. BMC Bioinformatics, 13(Suppl 10), 2012, S7.
28. 28 Rand, W.M., Objective criteria for the evaluation of clustering methods. J Am Stat Assoc 66 (1971), 846–850.
29. 29 Langfelder, P., Luo, R., Oldham, M.C., et al. Is my network module preserved and reproducible?. PLoS Comput Biol, 7, 2011, e1001057.
30. 30 Handl, J., Knowles, J., Kell, D., Computational cluster validation in post-genomic data analysis. Bioinformatics 21 (2005), 3201–3212.
31. 31 Garge, N.R., Page, G.P., Sprague, A.P., et al. Reproducible clusters from microarray research: whither?. BMC Bioinformatics, 6(Suppl 2), 2005, S10.
32. 32 Giancarlo, R., Scaturro, D., Utro, F., Computational cluster validation for microarray data analysis: experimental assessment of Clest, Consensus Clustering, Figure of Merit, Gap Statistics and Model Explorer. BMC Bioinformatics, 9, 2008, 462.
33. 33 Smolkin, M., Ghosh, D., Cluster stability scores for microarray data in cancer studies. BMC Bioinformatics, 4, 2003, 36.
34. 34 Kapp, A., Tibshirani, R., Are clusters found in one dataset present in another dataset?. Biostatistics 8 (2007), 9–31.
35. 35 Horvath S. Weighted Network Analysis: Applications in Genomics and Systems Biology, Berlin, Germany: Springer 2011.
36. 36 Han, J., Bertin, N., Hao, T., et al. Evidence for dynamically organized modularity in the yeast protein-protein interaction network. Nature 430 (2004), 88–93.
37. 37 Horvath, S., Dong, J., Geometric interpretation of gene coexpression network analysis. PLoS Comput Biol, 4, 2008, e1000117.
38. 38 Nemeth, E., Ganz, T., Regulation of iron metabolism by hepcidin. Annu Rev Nutr 26 (2006), 323–342.
39. 39 Salzman, N.H., Hung, K., Haribhai, D., et al. Enteric defensins are essential regulators of intestinal microbial ecology. Nat Immunol 11 (2010), 76–83.
40. 40 Cadwell, K., Patel, K.K., Maloney, N.S., et al. Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine. Cell 141 (2010), 1135–1145.
41. 41 Wehkamp, J., Fellermann, K., Herrlinger, K.R., et al. Human beta-defensin 2 but not beta-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease. Eur J Gastroenterol Hepatol 14 (2002), 745–752.
42. 42 Fahlgren, A., Hammarstrom, S., Danielsson, A., et al. Increased expression of antimicrobial peptides and lysozyme in colonic epithelial cells of patients with ulcerative colitis. Clin Exp Immunol 131 (2003), 90–101.
43. 43 Voss, E., Wehkamp, J., Wehkamp, K., et al. NOD2/CARD15 mediates induction of the antimicrobial peptide human beta-defensin-2. J Biol Chem 281 (2006), 2005–2011.
44. 44 Vora, P., Youdim, A., Thomas, L.S., et al. Beta-defensin-2 expression is regulated by TLR signaling in intestinal epithelial cells. J Immunol 173 (2004), 5398–5405.
45. 45 Simms, L.A., Doecke, J.D., Walsh, M.D., et al. Reduced α-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease. Gut 57 (2008), 903–910.
46. 46 Steck, N., Mueller, K., Schemann, M., et al. Bacterial proteases in IBD and IBS. Gut, 2011.
47. 47 Cleynen, I., Jüni, P., Bekkering, G.E., et al. Genetic evidence supporting the association of protease and protease inhibitor genes with inflammatory bowel disease: a systematic review. PLoS One, 6, 2011, e24106.
48. 48 Ravi, A., Garg, P., Sitaraman, S.V., Matrix metalloproteinases in inflammatory bowel disease: boon or a bane?. Inflamm Bowel Dis 13 (2007), 97–107.
49. 49 Martens, E.C., Chiang, H.C., Gordon, J.I., Mucosal glycan foraging enhances fitness and transmission of a saccharolytic human gut bacterial symbiont. Cell Host Microbe 4 (2008), 447–457.